Jiangsu Lingyun Pharmaceutical Co., Ltd. is a distinguished manufacturer in the pharmaceutical industry, primarily focused on the development, manufacturing, and marketing of veterinary Active Pharmaceutical Ingredients (APIs) and intermediates. Established in 1999 and certified with Good Manufacturing Practice (GMP), the company has built a robust portfolio that includes notable products such as Toltrazuril, Ponazuril, Diclazuril, Decoquinate, Fipronil, and Zilpaterol HCL. Further solidifying its reputation, the wholly-owned subsidiary, Jiangsu Willing Bio-Tech Co., Ltd., founded in 2012, possesses both GMP certification and USFDA approval, offering a diverse range of products including Tulathromycin, Moxidectin, Selamectin, Imidacloprid, Doramectin, Milbemycin Oxime, and more.

Services include:
- Anatomical Therapeutic Chemical (ATC) Classification
- Development of veterinary APIs and intermediates
- Manufacturing of approved veterinary pharmaceutical products
- Marketing of diverse veterinary medicines

With its commitment to quality and innovation, Jiangsu Lingyun Pharmaceutical Co., Ltd. continues to enhance its contributions to the pharmaceutical industry. For more information, please visit lingyunchem.com.